ABBV Jan 2025 165.000 put
| Previous close | 28.51 |
| Open | 28.51 |
| Bid | 20.65 |
| Ask | 21.10 |
| Strike | 165.00 |
| Expiry date | 2025-01-17 |
| Day's range | 28.51 - 28.51 |
| Contract range | N/A |
| Volume | |
| Open interest | 190 |
- Yahoo Finance Video
FTC warns pharma companies on excessive drug patenting
The Federal Trade Commission (FTC) issued warning letters to several pharmaceutical companies, including AbbVie (ABBV) AstraZeneca (AZN), and Teva (TEVA), over excessive patenting of medications as Medicare negotiates drug costs with the pharma industry. Yahoo Finance Health Reporter Anjalee Khemlani explains the Biden administration's ideas to license patents to lower drug costs for patients. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.
ZacksPharma Stock Roundup: ABBV to Buy CERE, JNJ's 2024 View, LLY & NVS Get FDA Nod
AbbVie (ABBV) offers to acquire Cerevel Therapeutics for $8.7 billion. J&J (JNJ) announces sales and earnings growth expectations for 2024.
Motley Fool3 High-Yielding Dividend Stocks That Are Near Their 52-Week Lows
Buying these shares can provide you with some excellent recurring income while also diversifying your portfolio.
